Migration Biotherapeutics Ltd

We serve surgeons who operate on brain tumours in adults with a decoy nerve for Glioblastoma.


Glioblastoma is the most common primary brain tumour in adults. Median survival is around 14 months and no cure is available.


We are building a material acting as a ‘decoy-nerve’, directing the migration of brain tumour cells for therapeutic purposes.


Website and social media

UN Sustainable Development Goals

Contact us

    I'd like to contact this venture...